MedPath

Ethacrynic acid

Ethacrynic Acid Tablets USP

Approved
Approval ID

3b2b6ee1-1859-4b02-9ef2-5bbe6427f61a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 7, 2023

Manufacturers
FDA

TRUPHARMA LLC

DUNS: 078533947

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ethacrynic acid

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52817-367
Application NumberANDA211809
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ethacrynic acid
Product Specifications
Route of AdministrationORAL
Effective DateDecember 7, 2023
FDA Product Classification

INGREDIENTS (4)

ETHACRYNIC ACIDActive
Quantity: 25 mg in 1 1
Code: M5DP350VZV
Classification: ACTIB
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.